Suppr超能文献

P388小鼠白血病中的蒽环类药物耐药性及其通过钙拮抗剂的克服。

Anthracycline resistance in P388 murine leukemia and its circumvention by calcium antagonists.

作者信息

Kessel D, Wilberding C

出版信息

Cancer Res. 1985 Apr;45(4):1687-91.

PMID:3919944
Abstract

Daunorubicin transport was compared in P388 murine leukemia and in P388/Adramycin (ADR), an anthracycline-resistant subline. We can demonstrate an energy-dependent outward transport system in P388/ADR which limits drug accumulation. Although no calcium requirement for the outward transport process could be shown, several calcium antagonists inhibited outward transport of daunorubicin in P388/ADR and modified the drug resistance pattern. But these agents failed to alter calcium fluxes in either cell line, suggesting that their mode of action in these studies was not related to interactions with calcium-dependent processes. Accumulation differences could not account for the level of daunorubicin resistance observed in the P388/ADR cell line, nor could resistance be wholly circumvented by calcium antagonists.

摘要

比较了柔红霉素在P388小鼠白血病细胞和P388/阿霉素(ADR,一种耐蒽环类药物的亚系)中的转运情况。我们可以证明在P388/ADR细胞中存在一种能量依赖性外向转运系统,该系统限制了药物的积累。虽然未发现外向转运过程对钙有需求,但几种钙拮抗剂可抑制柔红霉素在P388/ADR细胞中的外向转运,并改变耐药模式。但这些药物未能改变两种细胞系中的钙通量,这表明它们在这些研究中的作用方式与钙依赖性过程的相互作用无关。积累差异无法解释P388/ADR细胞系中观察到的柔红霉素耐药水平,钙拮抗剂也不能完全克服耐药性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验